Driehaus Capital Management LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 938206 Chicago, IL

Back to CRNX Full portfolio

Position in CRNX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$232,299,887

-$65,049,410 QoQ

Shares Held

6,395,922

+0.1% QoQ

Ownership

6.07%

of shares outstanding

% of Portfolio

1.71%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

24 quarters on record

Voting authority Sole 85.55954872495319.ToString("F0")% Shared 0.ToString("F0")% None 14.44045127504682.ToString("F0")%

Common Shares in CRNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Driehaus Capital Management LLC holds $2,981,444,927 across 55 Biotechnology names. CRNX ranks #3 (7.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	949,225	$305,830,802
2	XENE	Xenon Pharmaceuticals Inc.	4,491,653	$261,189,621
3	CRNX	Crinetics Pharmaceuticals, Inc. This page	6,395,922	$232,299,887
4	APGE	Apogee Therapeutics, Inc.	1,920,800	$161,673,736
5	EWTX	Edgewise Therapeutics, Inc.	4,477,942	$141,055,173
6	SYRE	Spyre Therapeutics, Inc.	2,790,785	$140,767,195
7	DFTX	Definium Therapeutics, Inc.	5,911,889	$111,734,702
8	SEPN	Septerna, Inc.	4,395,572	$105,625,595

All Filings in CRNX

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$232,299,887	6,395,922	0.0%	Shares	Sole	2026-05-15
2026-03-31	$232,299,887	6,395,922	+0.1%	Shares	Sole	2026-05-15
2025-12-31	$297,349,297	6,387,740	-1.4%	Shares	Sole	2026-02-17
2025-09-30	$269,959,181	6,481,613	+1.3%	Shares	Sole	2025-11-14
2025-06-30	$184,064,719	6,400,025	+2.6%	Shares	Sole	2025-08-14
2025-03-31	$209,286,313	6,239,902	+1.6%	Shares	Sole	2025-05-15
2024-12-31	$313,990,045	6,141,014	+4.3%	Shares	Sole	2025-02-14
2024-09-30	$300,736,172	5,885,248	-3.7%	Shares	Sole	2024-11-14
2024-06-30	$273,764,228	6,112,173	+17.0%	Shares	Sole	2024-08-15
2024-03-31	$244,642,962	5,226,297	+3.7%	Shares	Sole	2024-05-15
2023-12-31	$179,321,670	5,039,957	-1.8%	Shares	Sole	2024-02-14
2023-09-30	$152,634,215	5,132,287	-3.1%	Shares	Sole	2023-11-14
2023-06-30	$95,471,545	5,298,088	+0.2%	Shares	Sole	2023-08-14
2023-03-31	$84,949,675	5,289,519	-6.0%	Shares	Sole	2023-05-15
2022-12-31	$102,932,815	5,624,744	-0.1%	Shares	Sole	2023-02-14
2022-09-30	$110,611,655	5,631,958	+2.9%	Shares	Sole	2022-11-14
2022-06-30	$102,098,660	5,474,459	+10.7%	Shares	Sole	2022-08-15
2022-03-31	$108,521,085	4,944,013	+3.1%	Shares	Sole	2022-05-16
2021-12-31	$136,187,255	4,793,638	+59.9%	Shares	Sole	2022-02-14
2021-09-30	$63,118,677	2,998,512	+10.7%	Shares	Sole	2021-11-15
2021-06-30	$51,042,501	2,707,825	+35.1%	Shares	Sole	2021-08-16
2021-03-31	$30,616,352	2,003,688	+37.8%	Shares	Sole	2021-05-17
2020-12-31	$20,515,460	1,453,966	+66.2%	Shares	Sole	2021-02-16
2020-09-30	$13,708,774	874,842	-1.3%	Shares	Sole	2020-11-16
2020-06-30	$15,536,070	886,762	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.